Cover Image

FDA-approved drugs in 2022: A brief outline

Saved in:

Bibliographic Details
Main Author:	Haitham Ahmed Al-Madhagi (Author)
Format:	Book
Published:	Elsevier, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023)

Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022)
by: Ghulam Shabir, et al.
Published: (2023)

FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
by: Davide Benedetto Tiz, et al.
Published: (2022)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024)

Ebanga™: The most recent FDA-approved drug for treating Ebola
by: Elahe Taki, et al.
Published: (2023)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021)

FDA approved ready to use phenylephrine
by: Pradeep Kumar Bhatia, et al.
Published: (2021)

An overview of FDA-approved vaccines & their innovators
by: Rebekah H. Griesenauer, et al.
Published: (2017)

A review of FDA approved drugs and their formulations for the treatment of breast cancer
by: Mohini Chaurasia, et al.
Published: (2023)

Selumetinib-A Comprehensive Review of the New FDA-Approved Drug for Neurofibromatosis
by: Surajit Gorai, et al.
Published: (2024)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024)

2020 FDA/EMA approvals for new immunotherapy drug technologies and applications
by: Maryam Monajati, et al.
Published: (2021)

Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer's Drugs
by: Débora Nunes, et al.
Published: (2022)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
by: Jyothi Dhuguru, et al.
Published: (2022)

THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA
by: article Editorial
Published: (2023)

The FDA has approved the first medical drug for the treatment of primary immunodeficiency APDS
by: article Editorial
Published: (2023)

Human radiolabeled mass balance studies supporting the FDA approval of new drugs
by: Anuradha Ramamoorthy, et al.
Published: (2022)

Network model‐based screen for FDA‐approved drugs affecting cardiac fibrosis
by: Angela C. Zeigler, et al.
Published: (2021)

Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA
by: Maryam Monajati, et al.
Published: (2024)

A Comprehensive Map of FDA-Approved Pharmaceutical Products
by: Hao Zhong, et al.
Published: (2018)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023)

Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
by: Joseph D Planer, et al.
Published: (2014)

FDA approval of Pfizer-BioNTech: Evaluating the significance of mRNA vaccine approval
by: Syed Abdullah Monawwer, et al.
Published: (2021)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
by: Amelia D. Dahlén, et al.
Published: (2022)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2020)

A brief historical outline of the development of labor analgesia
by: Michał Michalczyk, et al.
Published: (2018)

A brief historical outline of the development of labor analgesia
by: Michał Michalczyk, et al.
Published: (2018)

Screening of an FDA-Approved Library for Novel Drugs against <i>Y. pestis</i>
by: David Gur, et al.
Published: (2021)

THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024)

A Review of FDA-Approved Antiparasitic Drugs in USA for Sheep and Goats: Their Synthesis and Pharmaceutical Use
by: Davide Benedetto Tiz, et al.
Published: (2023)

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review
by: Paul C. Macklis, et al.
Published: (2020)

Structure-based virtual screening to predict Loxosceles spider venom natural inhibitors
by: Haitham Ahmed Al-Madhagi
Published: (2023)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Mostafa, et al.
Published: (2020)

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
by: Nader S. Abutaleb, et al.
Published: (2022)